Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins. - Wikidata - wikimedia - TriplyDB

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

http://www.wikidata.org/entity/Q33729671

about

Management, prognosis and predictors of unfavourable outcomes in patients newly hospitalized for transient ischemic attack: a real-world investigation from Italy How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Statin intolerance: diagnosis and remedies.Meta-Analyses of Statin Therapy for Primary Prevention Do Not Answer Key Questions: An Empirical Appraisal of 5 Years of Statin Meta-Analyses.Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke.

P2860

Q36254383-6E6A5E09-807E-4249-A938-E4E274925D89 Q36286263-0AAE28BD-09DB-49C7-AFF9-69509ECB6CA5 Q36386629-6C0A2DB6-C77D-4623-9057-E03A75A1ECFB Q37251490-D48800C2-3024-45EF-AA9D-C1D2216FA56E Q38430744-9B9370EE-9150-4C9C-8E6E-79BAA0FAA9F1 Q40769604-6191D637-AE8B-4DFB-B853-3C671A28F1DC Q55317625-55A3E5A4-4591-4DD2-9C2C-4887EE2D884C

P2860

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

http://www.wikidata.org/entity/Q33729671

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

@ast

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

@en

type

label

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

@ast

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

@en

prefLabel

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

@ast

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

@en

P1433

Q33729671-459AA7D5-928F-4B0A-8E04-9EE1358118A8

P1476

Q33729671-16EFA0D2-FDF0-4D66-8B9F-D46137176F7D

P2093

Q33729671-0CA853F0-35CC-436D-BE1B-45AA80BE7D55

Q33729671-114A8286-A359-466E-8890-630DDB037887

Q33729671-2B1460DA-15BA-4105-B69C-E1D7F08AE992

Q33729671-5A5062FD-2522-43B5-B710-D7712CC0E340

Q33729671-62F05EDC-D5B6-4975-A9D0-B9561C126B6C

P2860

Q33729671-096019CC-990E-477C-864A-846A7756E721

Q33729671-1819047D-9B87-413C-862C-46AE43FA917E

Q33729671-2324ECE6-556A-4996-843E-C60B2184B9BB

Q33729671-28A37D63-512F-4F13-85A2-3B7BD39E5A59

Q33729671-3213BFAB-2F5E-49F9-A4A0-867077B6D1F8

Q33729671-3319CB58-594F-45CC-BE15-6F326E776772

Q33729671-3686CB2F-409F-4993-944D-0DCC9F30E6FF

Q33729671-42D80C44-786A-4B8B-BD52-462A3821A3EB

Q33729671-4F267521-BEA0-4485-A1BD-B8DC125B4BA6

Q33729671-4F47C133-FF78-4FA6-B72A-164EF22D5C08

P304

Q33729671-D51198C6-D300-45F2-8CA4-A2107B709EAE

P31

Q33729671-01D7AADD-E1FD-4FA4-B9A2-CB0D2E05B7AF

Q33729671-d9a345de-8cdb-49ff-80ef-57540d7eebcb

P356

Q33729671-BADCD25E-2437-4164-84DD-D64829243369

P407

Q33729671-44925862-E8B3-44DD-AAEC-53A1C3A6A276

P433

Q33729671-F171084E-5C26-489D-B21F-C7DB5A7AC039

P478

Q33729671-3ADF44B3-E62A-44C2-9424-185859265F04

P577

Q33729671-E4F5E114-ECB6-48E6-A960-7E0168735720

P5875

Q33729671-4A7787D4-3EBD-4806-A3D0-234214C8D172

P698

Q33729671-0B3A9C76-5BA8-4FFF-9F1D-92DA77688F3F

P921

Q33729671-5C33CFEA-5CF2-4DE8-A5E3-DDB4A7E41112

P356

J.1600-0404.2010.01450.X

P1433

Acta Neurologica Scandinavica

P1476

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins.

@en

P2093

D K Y Chan

http://www.w3.org/2001/XMLSchema#string

F O'Rourke

http://www.w3.org/2001/XMLSchema#string

J C S Mak

http://www.w3.org/2001/XMLSchema#string

Q Shen

http://www.w3.org/2001/XMLSchema#string

W T Hung

http://www.w3.org/2001/XMLSchema#string

P2860

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

P304

188-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0404.2010.01450.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227743517

http://www.w3.org/2001/XMLSchema#string

P698

20979581

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio